AP NEWS

The Corporate Reputation of Pharma, 2017: The Patient Perspective - Asia Edition - ResearchAndMarkets.com

November 13, 2018

DUBLIN--(BUSINESS WIRE)--Nov 13, 2018--The “The Corporate Reputation of Pharma, 2017 - The Patient Perspective - Asia Edition” report has been added to ResearchAndMarkets.com’s offering.

Introducing the results of the 2017 (2nd) edition of The Corporate Reputation of Pharma - from the Perspective of Asian Patient Groups. In total, 101 Asian patient groups from across the region participated in the 2017 survey (with 35% of the respondents being based in Australasia).

Asian patient groups (and the patients they represent), on the whole, take a more positive view of the pharmaceutical industry than patient groups from elsewhere in the world. As many as 51% of the respondent Asian patient groups stated that the pharmaceutical industry as a whole had an Excellent or Good corporate reputation in 2017 (on a par with the 50% of Asian patient groups saying the same in 2016). The equivalent figure from patient groups worldwide in 2017 was 43%.

Companies Featured

AbbVie Astellas Pharma AstraZeneca Bayer Boehringer,ngelheim Bristol-Myers Squibb Eisai Eli Lilly (Lilly) GSK Gilead Sciences Janssen Merck & Co/MSD Novartis Otsuka Pfizer Roche Sanofi Takeda

Key Topics Covered

Executive Summary The Relationships that Asian Patient Groups have with Pharma, 2017 Industry-Wide Findings from Asian Patient Groups, 2017 Rankings of the 18 Pharma Companies, 2017 v. 2016 among Asian Patient Groups Familiar with the Companies Positionings of 11 Pharma Companies, 2017 v. 2016 among Asian Patient Groups that Work/Partner with the Companies Profiles of the 18 Companies, 2017

For more information about this report visit https://www.researchandmarkets.com/research/n3th2c/the_corporate?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181113005918/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Pharmaceuticals

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 11/13/2018 11:28 AM/DISC: 11/13/2018 11:28 AM

http://www.businesswire.com/news/home/20181113005918/en

AP RADIO
Update hourly